Delirium‐associated medication in people at risk: A systematic update review, meta‐analyses, and GRADE‐profiles
Open Access
- 11 October 2022
- journal article
- review article
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 147 (1), 16-42
- https://doi.org/10.1111/acps.13505
Abstract
Background Drug-associated delirium is a common but potentially preventable neuropsychiatric syndrome associated with detrimental outcomes. Empirical evidence for delirium-associated medication is uncertain due to a lack of high-quality studies. We aimed to further investigate the body of evidence for drugs suspected to trigger delirium. Methods A systematic update review and meta-analyses of prospective studies presenting drug associations with incident delirium in adult study populations was conducted. Two authors independently searched MEDLINE, PsycINFO, Embase, and Google Scholar dated from October 1, 2009 to June 23, 2020, after screening a previous review published in 2011. The most reliable results on drug-delirium associations were pooled in meta-analyses using the random-effects model. Quality of evidence was assessed using the GRADE-approach. This study is preregistered with OSF (DOI ). Results The 31 eligible studies, presenting results for 24 medication classes were identified. Meta-analyses and GRADE level of evidence ratings show no increased delirium risk for Haloperidol (OR: 0.96, 95% CI 0.72-1.28; high-quality evidence), Olanzapine (OR: 0.25, 95% CI 0.15-0.40), Ketamine (OR: 0.72, 95% CI 0.35-1.46) or corticosteroids (OR: 0.69, 95% CI 0.32-1.50; moderate quality evidence, respectively). Low-level evidence suggests a three-fold increased risk for anticholinergics (OR: 3.11, 95% CI 1.04-9.26). Opioids, benzodiazepines, H-1-antihistamines, and antidepressants did not reach reliable evidence levels in our analyses. Conclusion We investigated the retrievable body of evidence for delirium-associated medication. The results of this systematic review were then interpreted in conjunction with other evidence-based works and guidelines providing conclusions for clinical decision-making.Keywords
This publication has 61 references indexed in Scilit:
- Delirium in elderly peopleThe Lancet, 2014
- GRADE guidelines 6. Rating the quality of evidence—imprecisionJournal of Clinical Epidemiology, 2011
- GRADE guidelines: 9. Rating up the quality of evidenceJournal of Clinical Epidemiology, 2011
- Postoperative Opioid Consumption and Its Relationship to Cognitive Function in Older Adults with Hip FractureJournal of the American Geriatrics Society, 2011
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Identification and Management of In-Hospital Drug-Induced Delirium in Older PatientsDrugs & Aging, 2011
- Anesthesia and Postoperative Delirium in Older Adults Undergoing Hip SurgeryJournal of the American Geriatrics Society, 2011
- Administration of Olanzapine to Prevent Postoperative Delirium in Elderly Joint-Replacement Patients: A Randomized, Controlled TrialPsychosomatics, 2010
- The cognitive impact of anticholinergics: A clinical reviewClinical Interventions in Aging, 2009
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ, 2008